Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 22 | $32,753,140 |
| Sells | 0 | $0 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 11 Feb 2025 19:00 | OCX | Oncocyte Corp | JAMES ANDREA S. | Chief Financial Officer | 07 Feb 2025 | Purchase | 97,561 | 2.05 | 200,000 | D |
| 11 Feb 2025 17:00 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 07 Feb 2025 | Purchase | 1,077,600 | 2.05 | 2,209,080 | I |
| 10 Feb 2025 20:43 | OCX | Oncocyte Corp | BROADWOOD PARTNERS, L.P. | 10% | 06 Feb 2025 | Purchase | 660,207 | 2.05 | 1,353,424 | D |
| 10 Feb 2025 20:43 | OCX | Oncocyte Corp | BROADWOOD PARTNERS, L.P. | 10% | 06 Feb 2025 | Purchase | 4,505,488 | 2.05 | 9,236,250 | D |
| 04 Feb 2025 16:45 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 31 Jan 2025 | Purchase | 890 | 2.01 | 1,789 | I |
| 04 Feb 2025 16:45 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 04 Feb 2025 | Purchase | 25 | 2.02 | 50 | I |
| 31 Jan 2025 17:00 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 29 Jan 2025 | Purchase | 3,880 | 2.01 | 7,799 | I |
| 31 Jan 2025 17:00 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 30 Jan 2025 | Purchase | 318 | 2.01 | 639 | I |
| 15 Jan 2025 17:00 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 13 Jan 2025 | Purchase | 5,669 | 2.08 | 11,792 | I |
| 15 Jan 2025 17:00 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 14 Jan 2025 | Purchase | 100 | 2.08 | 208 | I |
| 15 Jan 2025 17:00 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 14 Jan 2025 | Purchase | 10,286 | 2.15 | 22,115 | I |
| 27 Dec 2024 21:49 | OCX | Oncocyte Corp | SMITH PATRICK W | 10% | 26 Dec 2024 | Purchase | 90,219 | 2.13 | 192,166 | I |
| 26 Dec 2024 18:17 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 26 Dec 2024 | Purchase | 12,500 | 2.108 | 26,350 | D |
| 09 Dec 2024 08:00 | OCX | Oncocyte Corp | JAMES ANDREA S. | Chief Financial Officer | 05 Dec 2024 | Purchase | 20,000 | 2.29 | 45,800 | D |
| 04 Oct 2024 19:40 | OCX | Oncocyte Corp | JAMES ANDREA S. | Chief Financial Officer | 02 Oct 2024 | Purchase | 33,670 | 2.97 | 100,000 | D |
| 04 Oct 2024 19:00 | OCX | Oncocyte Corp | BROADWOOD PARTNERS, L.P. | 10% | 02 Oct 2024 | Purchase | 1,315,339 | 2.948 | 3,877,619 | D |
| 15 Apr 2024 19:21 | OCX | Oncocyte Corp | BROADWOOD PARTNERS, L.P. | 10% | 11 Apr 2024 | Purchase | 2,420,000 | 2.9164 | 7,057,688 | D |
| 15 Apr 2024 06:04 | OCX | Oncocyte Corp | RIGGS JOSH | CEO and President | 11 Apr 2024 | Purchase | 3,390 | 2.95 | 10,000 | D |
| 15 Apr 2024 06:02 | OCX | Oncocyte Corp | ARNO ANDREW | Director | 11 Apr 2024 | Purchase | 33,898 | 2.95 | 99,999 | D |
| 15 Jun 2023 20:13 | OCX | Oncocyte Corp | KINGSLEY ALFRED D | Director | 14 Jun 2023 | Purchase | 30,000 | 0.2149 | 6,447 | D |
| 07 Apr 2023 17:12 | OCX | Oncocyte Corp | PURA VIDA INVESTMENTS, LLC | 10% | 05 Apr 2023 | Purchase | 663,000 | 0.3017 | 200,027 | I |
| 05 Apr 2023 21:35 | OCX | Oncocyte Corp | BROADWOOD PARTNERS, L.P. | 10% | 03 Apr 2023 | Purchase | 26,827,638 | 0.3017 | 8,093,898 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)